PN

Pennant Group IncNASDAQ PNTG Stock Report

Last reporting period 30 Jun, 2024

Updated 05 Nov, 2024

Last price

Market cap $B

1.114

Small

Exchange

XNAS - Nasdaq

PNTG Stock Analysis

PN

Neutral

Based on Eyestock quantitative analysis, PNTG`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

50/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

91.3 %

Undervalued

Market cap $B

1.114

Dividend yield

Shares outstanding

29.706 B

The Pennant Group, Inc. is a holding company, which engages in the provision of healthcare services to patients of all ages. The company is headquartered in Eagle, Idaho and currently employs 5,335 full-time employees. The company went IPO on 2019-09-19. The firm operates multiple lines of business, including home health, hospice and senior living, throughout Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. The company operates through two segments: home health and hospice services, which includes its home health, hospice and home care businesses, and senior living services, which includes its assisted living, independent living and memory care. The firm provides home health and hospice services through 95 agencies, and senior living services in 49 communities with 3,500 total units in its assisted living, independent living and memory care business communities. The company offers clinical services, such as nursing, speech, occupational and physical therapy, medical social work and home health aide.

View Section: Eyestock Rating